Observing the movement of cells inside an organism, following the development of an embryo in vivo over two days, or seeing how synapses form between neurons are the challenges faced by m
Research Programmes / Core Facilities
Cell and Developmental Biology
Structural and Computational Biology
Chemistry and Molecular Pharmacology
Core Facilities & Services
Scientists at IRB Barcelona are supported by an extensive range of common core facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible.
IRB Barcelona's partnerships, with organisations in areas of mutual interest and expertise, aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine
Selected IRB Barcelona publications
News & Events
Microscopy moves towards “nanoscopy” and transforms the life sciences
ELIXIR accelerates with major Horizon 2020 funding
European project to develop an innovative therapeutic strategy against epilepsy
Discovery of an unexpected function of a protein linked to neurodegenerative diseases
03JunSynaptic dysfunction in neurodegeneration
09JunInnovation Workshop Series – Introductory Course
11JunCareer progression in science – options beyond the bench
15JunDrosophila as a model in cancer
ELIXIR has been awarded €19 million from the EU to accelerate the implementation of Europe’s life-science data infrastructure over the next four years.
ECMED will be developed through a public-private consortium led by the University College London (UK), and will engage other 10 organizations from several European countries.
Until today, the proteins known as ubiquitin receptors have been associated mainly with protein degradation, a basic cell cleaning process.
Speaker: Patrick Verstreken, KU Leuven, Belgium
Technology transfer: turning academic results into business opportunities by Marc Ramis Castelltort, CEO at Tech & Business Innovation (TBI)
- Raül Insa, CEO, SOM Biotech
- Rosina Malagrida, Head of Public Engagement on Health Research, Institut de Recerca de la Sida IrsiCaixa
- Goretti Mallorquí, Scientific Officer, Research and Academic Administration Department, IRB Barcelona
- Dominique Monferrer, Regulatory Affairs Manager at Asphalion
- Marusela Oliveras, Junior Business Development Manager, Erasmus MC
- Jordi Quintana, Head of Business Development, Director of Drug Discovery Platform, PCB
- Markus Wilhelms, PhD, CEO and Co-Founder of usMIMA
Barcelona BioMed Conference
Organisers: Cayetano González, IRB Barcelona (Barcelona, Spain) and Marco Milán, IRB Barcelona (Barcelona, Spain)